In the current Covid situation and being a US company it may get expedited through the trials. Considering how phase 3 of Ryoncil for Covid19 ARDS could be completed and approved for within 6-8 months, where normally a phase 3 would take years, If this is proven safe and it is effective as it is claimed who knows it may be approved for ARDS within a year. And if it is as potent as it is claimed it may be a preferred treatmebt fir ARDS over Ryoncil.
Competition - Citius Novellus License Deal, page-8
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 45345 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 3875 | 2 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |